Get the tools used by (smart)2 investors.
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

Talphera IncNASDAQGM:TLPH

United States / Healthcare / Pharmaceuticals

Income Statement
Balance Sheet
Cash Flow Statement
EBITDA Reconciliation
Net Income Reconciliation
Forecasts
Valuation Ratios
Fiscal Years
Fiscal Half
Fiscal Quarters
Year To Date
Latest Twelve Months
Ascending
Descending
3 Years
5 Years
10 Years
Millions
Billions
Thousands
Ones
Standard Size
Common Size
Growth Rate
2019-12-31
FY-4
2020-12-31
FY-3
2021-12-31
FY-2
2022-12-31
FY-1
2023-12-31
FY
Revenue
2.3
5.4
0.4
-
0.7
Revenue Growth (YoY)
6.4%
136.6%
-93.0%
NM
NM
Cost of Revenues
-11.5
-10.0
-3.0
-3.3
-5.5
Gross Profit
-9.2
-4.6
-2.6
-3.3
-4.9
Gross Profit Margin
-401.0%
-85.5%
-695.2%
-
-751.9%
R&D Expenses
-4.7
-4.0
-2.4
-3.3
-5.5
Selling, General & Admin Expenses
-45.0
-36.3
-15.5
-17.0
-12.0
Other Inc / (Exp)
4.3
4.6
2.4
82.4
5.5
Operating Expenses
-45.3
-35.7
-15.5
62.1
-12.0
Operating Income
-54.5
-40.4
-18.1
58.8
-16.9
Net Interest Expenses
1.3
0.0
1.0
0.4
6.6
EBT, Incl. Unusual Items
-53.2
-40.4
-17.1
59.1
-10.3
Earnings of Discontinued Ops.
-
-
-17.9
-11.4
-8.1
Income Tax Expense
0.0
0.0
0.0
0.0
0.0
Net Income to Company
-53.2
-40.4
-35.1
47.8
-18.4
Minority Interest in Earnings
-
-
-
-
-
Net Income to Stockholders
-53.2
-40.4
-35.1
47.8
-18.4
Preferred Dividends & Other Adj.
0.0
0.0
17.9
5.9
8.1
Net Income to Common Excl Extra Items
-53.2
-40.4
-17.2
53.7
-10.3
Basic EPS (Cont. Ops)
-13.45
-9.47
-2.86
7.27
-0.72
Diluted EPS (Cont. Ops)
-13.45
-9.47
-2.86
7.25
-0.72
Weighted Average Basic Shares Out.
4.0
4.3
6.0
7.4
14.3
Weighted Average Diluted Shares Out.
4.0
4.3
6.0
7.4
14.3
EBITDA
-52.5
-39.1
-16.1
-20.2
-16.8
EBIT
-54.2
-41.0
-18.1
-20.4
-16.9
Revenue (Reported)
2.3
5.4
0.4
-
0.7
Operating Income (Reported)
-54.2
-41.0
-18.1
-25.3
-16.9
Operating Income (Adjusted)
-54.2
-41.0
-18.1
-20.4
-16.9
FY-4FY-3FY-2FY-1FY01234
presentment in Millions except per share data. All rights reserved. Terms Of Use